Gene Subnetworks Predict Risk of Leukemia Progression

This article originally appeared here.
Share this content:
Gene Subnetworks Predict Risk of Leukemia Progression
Gene Subnetworks Predict Risk of Leukemia Progression

(HealthDay News) – Subnetworks of interacting genes can predict the risk of disease progression requiring treatment in patients with chronic lymphocytic leukemia, according to a study published online July 26 in Blood.

Han-Yu Chuang, PhD, from the University of California San Diego in La Jolla, and colleagues performed a subnetwork-based analysis of gene expression profiles to determine the risk of disease progression in 130 patients with chronic lymphocytic leukemia.

The researchers identified 38 prognostic subnetworks that predicted the likelihood of disease progression requiring treatment from the date the sample was collected; this prediction was then validated in 2 independent groups. The prognostic subnetworks were found to be more accurate than established markers. For patients classified at diagnosis as having aggressive disease there was reduced divergence in gene expression over time, compared to those with indolent disease. Levels of expression varied over time, but increased similarity was noted at later time points before therapy.

"As such, these results have implications for understanding cancer evolution and for the development of novel treatment strategies for patients with chronic lymphocytic leukemia," Chuang and colleagues conclude.

Two authors were partially supported by grants from Pfizer and Agilent Labs. One author is an employee of Roche Molecular Systems and another is an employee of MLL Münchner Leukämielabor.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs